PSI CRO   Report issue

For profit Phase 2 Phase 3
Founded: Baarerstrasse Switzerland (1995)

Organization Overview

First Clinical Trial
2008
NCT00668850
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Physician Services Incorporated | PSI | PSI CRO | PSI CRO AG | PSI Pharma Support Intl

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Multiple Sclerosis (Phase 2)

Nausea (Phase 3)

Sclerosis (Phase 2)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 8